Schwab Family Cancer Center proud of clinical trial success

Schwab Family Cancer Center proud of clinical trial success

More About Schwab Family Cancer Center proud of clinical trial success

Photo caption: Gene Drees, Finzel, with his doctor, UPMC Western Maryland Medical Oncologist Faye Yin. “These drugs are lifesaving, and Gene is one of the best patients I’ve ever had,” Dr. Yin said. “He quit smoking, and he’s been very honest. I tell other patients about his story. We are going to keep him around so we can keep bragging about him.”

CUMBERLAND, Md. – UPMC Western Maryland’s Schwab Family Cancer Center is one of 700 institutions around the country participating in a cutting-edge clinical trial that is making a difference in the lives of lung cancer patients both regionally and across the United States.
The Lung-MAP clinical trial is a cooperative group study sponsored by the National Cancer Institute. The Schwab Family Cancer Center has enrolled 12 patients for the study. Clinical trials like Lung-MAP involve studying new treatments and medications in an effort to get them approved for use.
Clinical Research Coordinators Mickie Seletyn and Barbara Wood have front-row seats to the doors that trials like Lung-MAP can open for cancer patients.
“Lung-MAP is a study for advanced non-small-cell lung cancer patients who are in Stage IV and have undergone treatment which failed,” Mickie said. “Once they have failed their first therapy, they are eligible for the Lung-MAP study.
“The trial involves molecular profiling. I tell patients it looks at their cancer and determines what kind of personality it has. It looks for specific mutations which could respond more favorably with different options of treatment other than chemotherapy. The medications are targeted therapies, and one way to describe it is like using a rifle instead of a shotgun. They target the cancer cells, causing less damage to healthy tissue.”
The Lung-MAP trial is unique because it was the first trial designed to have a master protocol and then several sub-protocols that can be opened and closed as one fills up. If a patient is in one sub-protocol and it works for a while but then stops, they can be moved to a new protocol without starting completely over.
“Clinical trials are optional,” Barbara said. “The patient may decline participation at any time. The decision to participate is made in consultation with the treating oncologist. Most of the time our patients are honored to be asked to participate. They are selfless. Everyone has the attitude that if they can help someone else by participating in the study, they are doing some good.”
Trials like Lung-MAP have been provided as options at the Schwab Family Cancer Center since 2007. That year, five Schwab Family Cancer Center patients joined 10,000 other patients around the country in a very important breast cancer trial designed to determine which patients could be safely treated without chemotherapy. After nearly 12 years, the trial findings were finally presented at a national oncology conference, and now there are new options because of these patients.
“The benefit of having the clinical trials here at UPMC Western Maryland is very clear. Our patients can take advantage of whatever new drugs are out there,” said Dr. Blanche Mavromatis, Medical Director, Oncology Clinical Trials. “We are very excited about the Lung-MAP trial. It’s very cutting edge and, as a result, progress is being made and fewer people are dying from lung cancer. We still have a lot of progress we need to make. It’s important to note that these trials are constantly changing with the times and technology. There are new drugs constantly being added to the different sub-protocols of the Lung-MAP.”
Lung cancer is the most common kind of cancer in the region UPMC Western Maryland serves, and parallels data nationwide. “It’s second only to prostate cancer in frequency for men and breast cancer for women,” Dr. Mavromatis said. “It is very common, and, unfortunately, we have a population here that is at risk. It’s a difficult disease and there is unmet need we are happy to help fill through our clinical trials.”
The trial has been beneficial for a number of patients, including Gene Drees of Finzel, Md. A lifelong smoker, Gene was diagnosed with Stage IV lung cancer in 2016. “They told me if my regular treatment did not work that I was a candidate for the trial.”
Though Gene’s treatment appeared to work initially, his cancer came back, and so he was administered 48 doses of immunotherapy as part of the Lung-MAP trial over the next two years.
“I knew right away I was going to try it,” he said. “My breathing was impacted to the point where I had to be on oxygen, and I was in a lot of pain.”
Now three years removed from the start of his participation in the trial, his condition has stabilized to the point where he can enjoy traveling with his family and fulfilling his duties as a self-described full-time grandpa.
“I’d tell anyone thinking about participating to go for it,” Gene said. “Don’t give up and keep a positive attitude. I can pretty well do everything I used to do again; it just takes me a little longer and it makes me more tired.”
Gene’s doctor, Medical Oncologist Faye Yin, said she was pleased he took the opportunity to participate in the Lung-MAP trial. “These drugs are lifesaving, and Gene is one of the best patients I’ve ever had. He quit smoking, and he’s been very honest. I tell other patients about his story. We are going to keep him around so we can keep bragging about him.”
As the Lung-MAP trial continues to develop and progress, so too will other trials that will one day lead to lifesaving treatment. Currently at the Schwab Family Cancer Center, a total of 30 active studies are under way involving all kinds of cancers.
“Every treatment that we have to treat cancer was in a clinical trial at some point,” Mickie said. “Everything is changing so quickly. Our doctors do an amazing job of keeping up to date with new clinical trials and treatment protocols. They are very good at what they do.”
While scientific proof of the success of the trials may take years to be published, Gene’s wife, Debbie Drees, sees the value of trials like Lung-MAP every day. “When they first mentioned the word cancer, I cried my eyes out thinking I was going to lose him,” said Debbie. “Now, I’m more positive, and know he’ll be around for years. I don’t know what I would do without him. We couldn’t ask for better people to take care of him. It takes special people to do this job.”

Tags: local events

Posted By: UPMC Western Maryland

Event Details

Date: June 11, 2020

Share This Event

More About this Event Poster: UPMC Western Maryland

In 2018, WMHS and UPMC joined together in a clinical affiliation to work cooperatively to enhance healthcare services and to strengthen the delivery of quality care, transform care delivery and reduce the total cost of providing care in the community. In March 2019, the Boards of Directors of both WMHS and UPMC signed a non-binding letter of intent to negotiate an affiliation agreement. Following a nine-month regulatory review and due diligence process by WMHS and UPMC, the Boards co-signed a binding integration and affiliation agreement on January 15, 2020, setting February 1, as the target date for finalizing the affiliation.

“Throughout our research and discussions with UPMC, we became increasingly confident and excited about becoming part of a world-class academic medical center which shares our vision for providing quality patient care,” said Rolf Haarstad, chair of the WMHS Board of Directors. “Our mutual mission is to continue to bring cutting-edge, evidence-based medicine to patients close to home.”

“UPMC has a long, successful track record of affiliations with like-minded hospitals. We know how much this hospital means to the region, and we are thrilled that WMHS has chosen to join UPMC,” said Leslie C. Davis, senior vice president, UPMC, and executive vice president and chief operating officer, UPMC Health Services Division.

UPMC has committed to make certain capital investments to enhance services and upgrade facilities in the Western Maryland region. These investments by UPMC, along with investments that the WMHS Foundation has made and continues to make, will help ensure that UPMC Western Maryland will continue to provide state-of-the-art, quality healthcare for residents as well as maintaining its position as one of the largest employers in the region for years to come.

The new affiliation does not affect patients’ insurance coverage. UPMC Western Maryland will continue to honor the contracts it has in place with regional and national insurers and has reaffirmed its commitment to continue working with multiple payors in the future.

The board of UPMC Western Maryland consists of 12 directors, including 8 appointed by the current WMHS board and 4 designated by the UPMC board.

About UPMC
A $20 billion health care provider and insurer, Pittsburgh-based UPMC is inventing new models of patient-centered, cost-effective, accountable care. The largest nongovernmental employer in Pennsylvania, UPMC integrates 89,000 employees, 40 hospitals, 700 doctors’ offices and outpatient sites, and a nearly 3.6 million-member Insurance Services Division, the largest medical insurer in western Pennsylvania. In the most recent fiscal year, UPMC contributed $1.2 billion in benefits to its communities, including more care to the region’s most vulnerable citizens than any other health care institution, and paid $587 million in federal, state and local taxes. Working in close collaboration with the University of Pittsburgh Schools of the Health Sciences, UPMC shares its clinical, managerial and technological skills worldwide through its innovation and commercialization arm, UPMC Enterprises, and through UPMC International. U.S. News & World Report consistently ranks UPMC Presbyterian Shadyside on its annual Honor Roll of America’s Best Hospitals and ranks UPMC Children’s Hospital of Pittsburgh on its Honor Roll of America’s Best Children’s Hospitals. For more information, go to

Would you like to add your event at

Town Planner is a community-minded organization. We're all about keeping things local and promoting hometown pride! That's why we're glad to offer you this medium to inform the public about your event. Post it today and it will appear on our website, our newsletter, and our mobile app.

As a general rule, we welcome the submission of events from charities, non-profit organizations, and municipal or community organizations such as mayor's offices, churches, schools, and the like. To get started, simply create an account. It's free and easy and you'll be able to start posting events as soon as you receive your authorization email.

If you're a business owner or you wish to promote a for-profit event, your event may be subject to the policies of your local Town Planner publisher. Some publishers may charge a nominal fee for such events, or reject them if they compete with other events from paying sponsors. To learn more about your local publisher's policies, or to inquire about adding a coupon or display ad for your business, please use our contact form.

Please keep in mind that Town Planner is a family-friendly publication and we reserve the right to reject any event that is deemed offensive, obscene, or otherwise inappropriate for inclusion on our site.

Remember that we're not just online! If you do business in an area with a local Town Planner publisher, our beautiful full color wall calendar is delivered free each December to thousands of homes in your community. Most people who receive the calendar hang it up in a prominent place and keep it all year long, making sure your business is On Display Every Day!

We're looking to bring the Town Planner to even more communities across America. If you or someone you know have an entrepreneurial spirit and would like to promote local businesses and build hometown pride while achieving financial security for yourself, why not look into becoming a Town Planner publisher?

Comments, Questions, or Concerns?

We're here to help! Email Us

Town Planner - Quickly Becoming America's Calendar!
Give Us Your Feedback!